The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children

Annals of Thoracic Medicine

Volumn 7, Issue 4, 2012, Pages 175-204

  Al Moamary, Mohamed S ^a   Alhaider, Sami A ^b   Al Hajjaj, Mohamed S ^c   Al Ghobain, Mohammed O ^a   Idrees, Majdy M ^d   Zeitouni, Mohammed O ^b   Al Harbi, Adel S ^d   Al Dabbagh, Maha M ^e   Al Matar, Hussain ^f   Alorainy, Hassan S ^b  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d The General Directorate of Armed Forces Health Services   (Saudi Arabia)

^e KING FAHD ARMED FORCES HOSPITAL   (Saudi Arabia)

^f IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Asthma; asthma control test; guidelines; Saudi Arabia

Indexed keywords

ACETYLSALICYLIC ACID; ALKANE; ALLERGEN; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CHLOROFLUOROCARBON; CHOLINERGIC RECEPTOR BLOCKING AGENT; CICLESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE; FORMOTEROL; HYDROCORTISONE; HYDROFLUROALKANE; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; PREDNISOLONE; SALBUTAMOL; SALMETEROL; STEROID; THEOPHYLLINE; TIOTROPIUM BROMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADD ON THERAPY; ADRENAL INSUFFICIENCY; ADULT; AEROSOL; AIR POLLUTANT; AIR POLLUTION; ALLERGIC ASTHMA; AMBIENT AIR; ANAMNESIS; ANAPHYLAXIS; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; ASTHMA CONTROL TEST; BITTER TASTE; BREATH ACTUATED INHALER; CATARACT; CHILD; CHILDHOOD ASTHMA CONTROL TEST; CORTICOSTEROID INDUCED OSTEOPOROSIS; COST EFFECTIVENESS ANALYSIS; COUGH VARIANT ASTHMA; COUGHING; DEVICE SAFETY; DIABETES MELLITUS; DIAGNOSTIC TEST; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FATALITY; DRUG FORMULATION; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; DYSPHONIA; DYSPNEA; EDUCATION PROGRAM; EVIDENCE BASED PRACTICE; EXERCISE INDUCED ASTHMA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HEART ARRHYTHMIA; HOSPITAL CARE; HUMAN; HYPERTENSION; IMMUNOTHERAPY; INFLUENZA VACCINATION; INHALATION SPACER; INHALATION TEST; INHALER; INJECTION SITE CONTUSION; INJECTION SITE PAIN; INTENSIVE CARE; LOW DRUG DOSE; MAINTENANCE THERAPY; MEDICAL NEBULIZER; METERED DOSE INHALER; MUSCLE WEAKNESS; NAUSEA AND VOMITING; OBESITY; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; OROPHARYNX CANDIDIASIS; OUTPATIENT CARE; OXYGEN THERAPY; PATIENT COMPLIANCE; PATIENT EDUCATION; PHENOTYPE; PHYSICAL EXAMINATION; POWDER INHALER; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREGNANCY; PRESSURIZED METERED DOSE INHALER; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; RESPIRATORY AND ASTHMA CONTROL IN KIDS TEST; RISK ASSESSMENT; RISK REDUCTION; SCORING SYSTEM; SEIZURE; SIDE EFFECT; SKIN MANIFESTATION; SKIN THINNING; SPIROMETRY; THORAX RADIOGRAPHY; TREATMENT PLANNING; TREATMENT RESPONSE; WHEEZING; XEROSTOMIA;

EID: 84870160262     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: 10.4103/1817-1737.102166     Document Type: Article

References (303)

1. Al Frayh AR, Shakoor Z, Gad El Rab MO, Hasnain SM. Increased prevalence of asthma in Saudi Arabia. Ann Allergy Asthma Immunol 2001;86:292-6. (Pubitemid 32240213)
2. Stewart WF, Ricci JA, Chee E, Morganstein D. Lost productive work time costs from health conditions in the United States: Results from the American Productivity Audit. J Occup Environ Med 2003;45:1234-46. (Pubitemid 37541937)
3. Al-Mobeireek A. Prescribing for asthmatic children in primary care. Are we following the guidelines? Saudi Med J 2003;24:1274. (Pubitemid 37527341)
4. Dashash NA, Mukhtar SH. Prescribing for asthmatic children in primary care. Are we following guidelines? Saudi Med J 2003;24:507-11. (Pubitemid 36826806)
5. Al-Moamary MS, Al-Hajjaj MS, Idrees MM, Zeitouni MO, Alanezi MO, Al-Jahdal HH, et al. The Saudi Initiative for asthma. Ann Thorac Med 2009;4:216-33.
6. Wechsler ME. Managing asthma in primary care: Putting new guideline recommendations into context. Mayo Clinic Proc 2009;84:707-17.
7. Al-Ghamdi BR, Mahfouz AA, Abdelmoneim I, Khan MY, Daffallah AA. Altitude and bronchial asthma in south-western Saudi Arabia. East Mediterr Health J 2008;14:17-23. (Pubitemid 351753088)
8. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, et al. Worldwide severity and control of asthma in children and adults: The global asthma insights and reality surveys. J Allergy Clin Immunol 2004;114:40-7. (Pubitemid 39022491)
9. Abudahish A, Bella H. Primary care physicians perceptions and practices on asthma care in Aseer region, Saudi Arabia. Saudi Med J 2006;27:333-7.
10. Alamoudi O. Prevalence of respiratory diseases in hospitalized patients in Saudi Arabia: A 5 years study 1996-2000. Ann Thorac Med 2006;1:76-80. (Pubitemid 44395070)
11. Colver AF. Underdiagnosis and undertreatment of asthma in childhood. Br Med J (Clin Res Ed) 1983;286:1511-2.
12. Speight AN, Lee DA, Hey EN. Undrediagnosis and undertreatment of asthma in childhood. Br Med J (Clin Res Ed) 1983;286:1253-6.
13. Al-Jahdali HH, Al-Hajjaj MS, Alanezi MO, Zeitoni MO, Al-Tasan TH. Asthma control assessment using asthma control test among patients attending 5 tertiary care hospitals in Saudi Arabia. Saudi Med J 2008;29:714-7.
14. Al Frayh AR. Asthma patterns in Saudi Arabian children. J R Soc Health 1990;110:98-100. (Pubitemid 20293767)
15. Al Frayh AR, Al Nahdi M, Bener AR, Jawadi TQ. Epidemiology of asthma and allergic rhinitis in two coastal regions of Saudi Arabia. Allergie Immunol (Paris) 1989;21:389-93. (Pubitemid 20077649)
16. Bener A, Al-Jawadi TQ, Ozkaragoz F, Anderson JA. Prevalence of asthma and wheeze in two different climatic areas of Saudi Arabia. Indian J Chest Dis Allied Sci 1993;35:9-15.
17. Hijazi N, Abalkhail B, Seaton A. Asthma and respiratory symptoms in urban and rural Saudi Arabia. Eur Respir J 1998;12:41-4. (Pubitemid 28325651)
18. Alshehri MA, Abolfotouh MA, Sadeg A, Al Najjar YM, Asindi AA, Al Harthi AM, et al. Screening for asthma and associated risk factors among urban school boys in Abha city. Saudi Med J 2000;21:1048-53. (Pubitemid 33694871)
19. Al-Kabbaa AF, Al-Shamrani KM, Salih MA. Does the management of bronchial asthma by family physicians meet standards of the national protocol? J Family Community Med 2002;9:21-5.
20. Al Ghobain MO, Al-Hajjaj MS, Al Moamary MS. Asthma prevalence among 16-to 18-year-old adolescents in Saudi Arabia using the ISAAC questionnaire. BMC Public Health 2012;12:239.
21. Sobki SH, Zakzouk SM. Point prevalence of allergic rhinitis among Saudi children. Rhinology 2004;42:137-40. (Pubitemid 39307378)
22. Duran-Tauleria E, Rona RJ. Geographical and socioeconomic variation in the prevalence of asthma symptoms in English and Scottish children. Thorax 1999;54:476-81. (Pubitemid 29241617)
23. Hamid Q, Tulic MK. New insights into the pathophysiology of the small airways in asthma. Ann Thorac Med 2007;28:33-2.
24. Cohn L, Homer RJ, Marinov A, Rankin J, Bottomly K. Induction of airway mucus production By T helper 2 (Th2) cells: A critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med 1997;186:1737-47. (Pubitemid 27506286)
25. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003;9:582-8. (Pubitemid 36597105)
26. Alzoghaibi MA, Bahammam AS. Circulating LTB4 and Eotaxin-1 in stable asthmatics on inhaled corticosteroids and long-acting ß 2-agonists. Ann Thorac Med 2006;1:67-70. (Pubitemid 44395068)
27. Humbert M, Corrigan CJ, Kimmitt P, Till SJ, Kay AB, Durham SR. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 1997;156(3 Pt 1):704-8. (Pubitemid 27396404)
28. Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR Jr. Roles of cysteinyl leukotrienes in airway infammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003;111(1 Suppl):S18-34.
29. Tobin MJ. Asthma, airway biology, and nasal disorders in AJRCCM 2003. Am J Respir Crit Care Med 2004;169:265-76. (Pubitemid 38114543)
30. Linzer J. Review of Asthma: Pathophysiology and Current Treatment Options. Clin Pediatr Emerg Med 2007;8:87-95.
31. Kendrick AH, Higgs CM, Whitfeld MJ, Laszlo G. Accuracy of perception of severity of asthma: Patients treated in general practice. BMJ 1993;307:422-4. (Pubitemid 23227471)
32. An SS, Bai TR, Bates JH, Black JL, Brown RH, Brusasco V, et al. Airway smooth muscle dynamics: A common pathway of airway obstruction in asthma. Eur Respir J 2007;29:834-60. (Pubitemid 46722226)
33. Kinet JP. The high-affnity IgE receptor (Fc epsilon RI): From physiology to pathology. Annu Rev Immunol 1999;17:931-72.
34. King GG, Pare PD, Seow CY. The mechanics of exaggerated airway narrowing in asthma: The role of smooth muscle. Respir Physiol 1999;118:1-13. (Pubitemid 29475015)
35. James AL, Pare PD, Hogg JC. The mechanics of airway narrowing in asthma. Am Rev Respir Dis 1989;139:242-6. (Pubitemid 19030451)
36. Niimi A, Matsumoto H, Takemura M, Ueda T, Chin K, Mishima M. Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med 2003;168:983-8. (Pubitemid 37267177)
37. Prevention GsfAma. Global Initiative for Asthma (GINA). Available from: http://www.ginAsthma.org. [Last accessed on 2012 Jun. 02].
38. prevention GsfAma. Global Initiative for Asthma in children 5 years and younger. 2009 Available from: http://www.ginAsthma.org. [Last accessed on 2012 Jun. 02].
39. Bousquet J, Clark TJ, Hurd S, Khaltaev N, Lenfant C, O'Byrne P, et al. GINA guidelines on asthma and beyond. Allergy 2007;62:102-12. (Pubitemid 46091634)
40. Busse WW. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics-2002. J Allergy Clin Immunol 2002;110(5 Suppl):S141-219.
41. Jadad AR, Moher M, Browman GP, Booker L, Sigouin C, Fuentes M, et al. Systematic reviews and meta-analyses on treatment of asthma: Critical evaluation. BMJ 2000;320:537-40. (Pubitemid 30175797)
42. Stempel DA, McLaughin TP, Stanford RH, Fuhlbrigge AL. Patterns of asthma control: A 3-year analysis of patient claims. J Allergy Clin Immunol 2005;115:935-9. (Pubitemid 40616205)
43. Horne R, Price D, Cleland J, Costa R, Covey D, Gruffydd-Jones K, et al. Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med 2007;7:8.
44. Gibson PG, Fujimura M, Niimi A. Eosinophilic bronchitis: Clinical manifestations and implications for treatment. Thorax 2002;57:178-82. (Pubitemid 34123895)
45. Al-Kassimi FA, Abba AA, Al-Hajjaj MS, Alhamad EH, Raddaoui E, Shaikh SA. Asthma masquerading as chronic obstructive pulmonary disease: A study of smokers fulflling the GOLD defnition of chronic obstructive pulmonary disease. Respiration 2011;82:19-27.
46. Alharbi M, Almutairi A, Alotaibi D, Alotaibi A, Shaikh S, Bahammam AS. The prevalence of asthma in patients with obstructive sleep apnoea. Prim Care Respir J 2009;18:328-30.
47. Berlow BA. Eight key questions to ask when your patient with asthma doesn't get better. Am Fam Physician 1997;55:183-9. (Pubitemid 27035018)
48. Price D. Asthma and allergic rhinitis: Linked in treatment and outcomes. Ann Thorac Med 2010;5:63-4.
49. Fireman P. Rhinitis and asthma connection: Management of coexisting upper airway allergic diseases and asthma. Allergy Asthma Proc 2000;21:45-54.
50. Al-Mobeireek AF, Al-Sarhani A, Al-Amri S, Bamgboye E, Ahmed SS. Chronic cough at a non-teaching hospital: Are extrapulmonary causes overlooked? Respirology 2002;7:141-6. (Pubitemid 34662946)
51. Al-Otair H, Bahammam AS. Unusual cause of respiratory distress misdiagnosed as refractory asthma. Ann Thorac Med 2006;1:28-3
52. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the asthma control test: A survey for assessing asthma control. J Allergy Clin Immunol 2004;113:59-65. (Pubitemid 38096162)
53. Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, et al. Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006;117:549-56. (Pubitemid 43340217)
54. Cowie RL, Underwood MF, Field SK. Asthma symptoms do not predict spirometry. Can Respir J 2007;14:339-42. (Pubitemid 350081681)
55. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med 1996;153(6 Pt 1):1802-11. (Pubitemid 26187903)
56. Witteman AM, Stapel SO, Perdok GJ, Sjamsoedin DH, Jansen HM, Aalberse RC, et al. The relationship between RAST and skin test results in patients with asthma or rhinitis: A quantitative study with purifed major allergens. J Allergy Clin Immunol 1996;97(1 Pt 1):16-25. (Pubitemid 26045964)
57. Creticos PS. Treatment options for initial maintenance therapy of persistent asthma: A review of inhaled corticosteroids and leukotriene receptor antagonists. Drugs 2003;63(Suppl 2):1-20. (Pubitemid 37421785)
58. Lemanske RF, Jr., Sorkness CA, Mauger EA, Lazarus SC, Boushey HA, Fahy JV, et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: A randomized controlled trial. JAMA 2001;285:2594-603. (Pubitemid 32479899)
59. Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, et al. Early intervention with budesonide in mild persistent asthma: A randomised, double-blind trial. Lancet 2003;361:1071-6. (Pubitemid 36369558)
60. Szefer SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, et al. Signifcant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002;109:410-8. (Pubitemid 34234189)
61. Masoli M, Weatherall M, Holt S, Beasley R. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax. 2005;60:730-4. Epub 2005/09/02. (Pubitemid 41297891)
62. O'Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005;171:129-36. (Pubitemid 40105411)
63. Cates CJ, Cates MJ. Regular treatment with formoterol for chronic asthma: Serious adverse events. Cochrane Database Syst Rev 2012;4:CD006923.
64. Pearlman DS, Greos L, La Force C, Orevillo CJ, Owen R, Higgins M. Bronchodilator effcacy of indacaterol, a novel once-daily beta2-agonist, in patients with persistent asthma. Ann Allergy Asthma Immunol 2008;101:90-5. (Pubitemid 352000750)
65. Sugihara N, Kanada S, Haida M, Ichinose M, Adachi M, Hosoe M, et al. 24-h bronchodilator effcacy of single doses of indacaterol in Japanese patients with asthma: A comparison with placebo and salmeterol. Respir Med 2010;104:1629-37.
66. Cazzola M, Segreti A, Matera MG. Novel bronchodilators in asthma. Curr Opin Pulm Med 2010;16:6-12.
67. Cazzola M, Matera MG. Novel long-acting bronchodilators for COPD and asthma. Br J Pharmacol 2008;155:291-9.
68. La Force C, Korenblat P, Osborne P, Dong F, Higgins M. 24-hour bronchodilator effcacy of single doses of indacaterol in patients with persistent asthma: Comparison with placebo and formoterol. Curr Med Res Opin 2009;25:2353-9.
69. Bjermer L, Diamant Z. The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace/Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio. Universita di Napoli: Secondo ateneo; 2002. p. 76-83. (Pubitemid 34873745)
70. Idrees MM, Al Moamary MS. Blocking leukotrienes optimize asthma control: The BLOC survey. Ann Thorac Med 2007;2:99-102.
71. Bisgaard H; Study Group on M, Respiratory Syncytial V. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003;167:379-83. (Pubitemid 36216419)
72. Straub DA, Minocchieri S, Moeller A, Hamacher J, Wildhaber JH. The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old. Chest 2005;127:509-14. (Pubitemid 40229310)
73. Straub DA, Moeller A, Minocchieri S, Hamacher J, Sennhauser FH, Hall GL, et al. The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma. Eur Respir J 2005;25:289-94. (Pubitemid 40246529)
74. Bisgaard H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, Menten J, et al. Montelukast reduces asthma exacerbations in 2-to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 2005;171:315-22. (Pubitemid 40223397)
75. Elias JA, Lee CG, Zheng T, Ma B, Homer RJ, Zhu Z. New insights into the pathogenesis of asthma. J Clin Invest 2003;111:291-7. (Pubitemid 36182201)
76. D'Amato G, Bucchioni E, Oldani V, Canonica W. Treating Moderate-to-Severe Allergic Asthma with a Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab). Treat Respir Med 2006;5:393-8. (Pubitemid 44968299)
77. Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001;108:184-90. (Pubitemid 32735398)
78. Busse WW, Morgan WJ, Gergen PJ, Mitchell HE, Gern JE, Liu AH, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 2011;364:1005-15.
79. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2006;2:CD000052.
80. Peters SP, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010;363:1715-26.
81. Nair A, Menzies D, Barnes M, Burns P, McFarlane L, Lipworth BJ. Respirable dose delivery of futicasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler. Br J Clin Pharmacol 2008;66:20-6. (Pubitemid 351822151)
82. Giraud V, Allaert FA, Roche N. Inhaler technique and asthma: Feasability and acceptability of training by pharmacists. Respir Med 2011;105:1815-22.
83. Giraud V, Allaert FA. Improved asthma control with breathactuated pressurized metered dose inhaler (pMDI): The SYSTER survey. Eur Rev Med Pharmacol Sci 2009;13:323-30.
84. Donnell D. Inhaled corticosteroid delivery systems: Clinical role of a breath-actuated device. Eur Rev Med Pharmacol Sci 2001;5:7-16. (Pubitemid 34177147)
85. Al-Jahdali HH, Al-Zahrani AI, Al-Otaibi ST, Hassan IS, Al-Moamary MS, Al-Duhaim AS, et al. Perception of the role of inhaled corticosteroids and factors affecting compliance among asthmatic adult patients. Saudi Med J 2007;28:569-73. (Pubitemid 47046037)
86. Alsheri MA. Comparative study of different inhaler devices in asthmatic children. Ann Saudi Med 2003;23:349-53.
87. Al-Wasil MA, Al-Mohaimeed A. Assessment of inhalation technique in primary care asthmatic patients using metered-dose inhalers with or without a spacer. Ann Saudi Med 2003;23:264-9. (Pubitemid 37259299)
88. Al-Haddad N, Nour A, Koshak E. Asthma care: Structural foundations at primary health care at Al-Qassim region, Saudi Arabia. Ann Thorac Med 2006;1:8-11. (Pubitemid 44271808)
89. Al Moamary MS. Unconventional therapy use among asthma patients in a tertiary care center in Riyadh, Saudi Arabia. Ann Thorac Med 2008;3:48-51.
90. Al-Haddad N, Al-Ansari SS, Al-Shari AT. Impact of asthma education program on asthma knowledge of general practitioners. Ann Saudi Med 1997;17:550-2. (Pubitemid 28182073)
91. Barnes NC. Can guideline-defned asthma control be achieved? The Gaining Optimal Asthma Control study. American journal of respiratory and critical care medicine 2004;170:830-1. (Pubitemid 39346475)
92. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, et al. Can guideline-defned asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004;170:836-44. (Pubitemid 39346477)
93. Gibson PG, Powell H. Written action plans for asthma: An evidencebased review of the key components. Thorax 2004;59:94-9. (Pubitemid 38223477)
94. Gibson PG, Powell H, Coughlan J, Wilson AJ, Hensley MJ, Abramson M, et al. Limited (information only) patient education programs for adults with asthma. Cochrane Database Syst Rev 2002:CD001005.
95. Zaraket R, Al-Tannir MA, Bin Abdulhak AA, Shatila A, Lababidi H. Parental perceptions and beliefs about childhood asthma: A cross-sectional study. Croat Med J 2011;52:637-43.
96. Al-Binali AM, Mahfouz AA, Al-Fif S, Naser SM, Al-Gelban KS. Asthma knowledge and behaviours among mothers of asthmatic children in Aseer, south-west Saudi Arabia. East Mediterr Health J 2010;16:1153-8.
97. Al-Yami SM, Mohajer KA, Al-Jeraisy MI, Batarfi AM, Abolfotouh MA. Recurrent visits and admissions of children with asthma in central Saudi Arabia. Saudi Med J 2010;30:921-4.
98. Al-Shimemeri A, Al-Ghadeer H, Giridhar H, Al-Jahdali M, Al-Moamary M, Khan J. Impact of an extensive Asthma education campaign for physicians on their drug prescription practices. Ann Thorac Med 2006;1:20-5. (Pubitemid 44271811)
99. Al-Mobeireek A. The efficacy of a management protocol in reducing emergency visits and hospitalizations in chronic asthmatics. Saudi Med J 2003;24:694-5. (Pubitemid 36833578)
100. Alamoudi OS. The effcacy of a management protocol in reducing emergency visits and hospitalizations in chronic asthmatics. Saudi Med J 2002;23:1373-9. (Pubitemid 36113494)
101. Al-Jahdali HH, Al-Omar AM, Al-Moamary MS, Al-Duhaim AS, Al-Hodeib AS, Hassan IS, et al. Implementation of the national asthma management guidelines in the emergency department. Saudi Med J 2004;25:1208-11. (Pubitemid 39334950)
102. Buist AS, Vollmer WM, Wilson SR, Frazier EA, Hayward AD. A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. Am J Respir Crit Care Med 2006;174:1077-87. (Pubitemid 44772077)
103. Al-Frayh AS, Hasnain SM, Gad-El-Rab MO, Schwartz B, Al-Mobairek K, Al-Sedairy ST. House dust mite allergens in Saudi Arabia: Regional variations and immune response. Ann Saudi Med 1997;17:156-60. (Pubitemid 27405977)
104. Hasnain SM, Fatima K, Al-Frayh A. Prevalence of airborne allergenic Amaranthus viridis pollen in seven different regions of Saudi Arabia. Ann Saudi Med 2007;27:259-63. (Pubitemid 47527592)
105. Troisi RJ, Speizer FE, Rosner B, Trichopoulos D, Willett WC. Cigarette smoking and incidence of chronic bronchitis and asthma in women. Chest 1995;108:1557-61.
106. Tunnicliffe WS, Fletcher TJ, Hammond K, Roberts K, Custovic A, Simpson A, et al. Sensitivity and exposure to indoor allergens in adults with differing asthma severity. Eur Respir J 1999;13:654-9. (Pubitemid 29180181)
107. Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH, Wiselka MJ, Leese J, Ayres J, et al. Randomised placebo-controlled crossover trial on effect of inactivated infuenza vaccine on pulmonary function in asthma. Lancet 1998;351:326-31. (Pubitemid 28052698)
108. Bueving HJ, van der Wouden JC, Raat H, Bernsen RM, de Jongste JC, van Suijlekom-Smit LW, et al. Infuenza vaccination in asthmatic children: Effects on quality of life and symptoms. Eur Respir J 2004;24:925-31. (Pubitemid 39642280)
109. Cates CJ, Cates MJ, Lasserson TJ. Regular treatment with formoterol for chronic asthma: Serious adverse events. Cochrane Database Syst Rev 2008;4:CD006923.
110. Humbert M, Holgate S, Boulet LP, Bousquet J. Asthma control or severity: That is the question. Allergy 2007;62:95-101. (Pubitemid 46090289)
111. Koshak EA. Classifcation of asthma according to revised 2006 GINA: Evolution from severity to control. Ann Thorac Med 2007;2:45-6.
112. Al-Moamary MS, Al-Kordi AG, Al Ghobain MO, Tamim HM. Utilization and responsiveness of the asthma control test (ACT) at the initiation of therapy for patients with asthma: A randomized controlled trial. BMC Pulm Med 2012;12:14.
113. Lababidi H, Hijaoui A, Zarzour M. Validation of the Arabic version of the asthma control test. Ann Thorac Med 2008;3:44-7. (Pubitemid 351520421)
114. Alanezi M, Al-Jahdali HH, Al-Hajjaj MS, Zeitoni MO, Al-Tasan TH. Levels of acceptance of Asthma Control Test questionnaire among Saudi patients attending 5 tertiary care hospitals in Saudi Arabia. Saudi Med J 2009;30:546-9.
115. Schatz M, Kosinski M, Yarlas AS, Hanlon J, Watson ME, Jhingran P. The minimally important difference of the Asthma Control Test. J Allergy Clin Immunol 2009;124:719-23 e1.
116. Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: Results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104(2 Pt 1):301-4. (Pubitemid 29420424)
117. Taramarcaz P, Gibson PG. Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis. Cochrane Database Syst Rev 2003:CD003570.
118. Dahl R, Nielsen LP, Kips J, Foresi A, Cauwenberge P, Tudoric N, et al. Intranasal and inhaled futicasone propionate for polleninduced rhinitis and asthma. Allergy 2005;60:875-81. (Pubitemid 40813808)
119. Philip G, Nayak AS, Berger WE, Leynadier F, Vrijens F, Dass SB, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004;20:1549-58. (Pubitemid 39457543)
120. Vignola AM, Humbert M, Bousquet J, Boulet LP, Hedgecock S, Blogg M, et al. Effcacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy 2004;59:709-17. (Pubitemid 38850345)
121. Ignacio-Garcia JM, Gonzalez-Santos P. Asthma self-management education program by home monitoring of peak expiratory fow. Am J Respir Crit Care Med 1995;151(2 Pt 1):353-9.
122. Hawkins G, McMahon AD, Twaddle S, Wood SF, Ford I, Thomson NC. Stepping down inhaled corticosteroids in asthma: Randomised controlled trial. BMJ 2003;326:1115.
123. Powell H, Gibson PG. High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children. Cochrane Database Syst Rev 2004:CD004109.
124. Boulet LP, Drollmann A, Magyar P, Timar M, Knight A, Engelstatter R, et al. Comparative effcacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma. Respir Med 2006;785:94-100.
125. Masoli M, Weatherall M, Holt S, Beasley R. Budesonide once versus twice-daily administration: Meta-analysis. Respirology 2004;9:528-34. (Pubitemid 40179760)
126. Bateman ED, Fairall L, Lombardi DM, English R. Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. Respira Res 2006;7:13.
127. Randell TL, Donaghue KC, Ambler GR, Cowell CT, Fitzgerald DA, van Asperen PP. Safety of the newer inhaled corticosteroids in childhood asthma. Paediatr Drugs 2003;5:481-504. (Pubitemid 36976118)
128. Berger WE. Levalbuterol: Pharmacologic properties and use in the treatment of pediatric and adult asthma. Ann Allergy Asthma Immunol 2003;90:583-91. (Pubitemid 36712662)
129. Shah L, Wilson AJ, Gibson PG, Coughlan J. Long acting betaagonists versus theophylline for maintenance treatment of asthma. Cochrane Database Syst Rev 2003:CD001281.
130. O'Byrne PM, Kerstjens HA. Inhaled beta 2-agonists in the treatment of asthma. N Engl J Med 1996;335:886-8. (Pubitemid 26304074)
131. Barnes PJ, Pedersen S. Effcacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis 1993;148(4 Pt 2):S1-26.
132. Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003:CD001117.
133. Powell H, Gibson PG. Initial starting dose of inhaled corticosteroids in adults with asthma: A systematic review. Thorax 2004;59:1041-5. (Pubitemid 39573922)
134. Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999;340:197-206. (Pubitemid 29063217)
135. Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma. Clin Exp Allergy 2001;31:616-24. (Pubitemid 34204287)
136. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: The OPTIMA randomized trial. Am J Respir Crit Care Med 2001;164(8 Pt 1):1392-7. (Pubitemid 33124016)
137. Godard P, Greillier P, Pigearias B, Nachbaur G, Desfougeres JL, Attali V. Maintaining asthma control in persistent asthma: Comparison of three strategies in a 6-month double-blind randomised study. Respir Med 2008;102:1124-31.
138. Kankaanranta H, Lahdensuo A, Moilanen E, Barnes PJ. Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: A comprehensive review. Respir Res 2004;5:17.
139. Lundborg M, Wille S, Bjermer L, Tilling B, Lundgren M, Telg G, et al. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: An effcacy and cost-effectiveness study. Curr Med Res Opin 2006;22:809-21. (Pubitemid 43875550)
140. Bateman ED, Bousquet J, Keech ML, Busse WW, Clark TJ, Pedersen SE. The correlation between asthma control and health status: The GOAL study. Eur Respir J 2007;29:56-62.
141. Chowdhury BA, Dal Pan G. The FDA and safe use of longacting beta-agonists in the treatment of asthma. N Engl J Med 2010;362:1169-71.
142. Koshak EA. New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist. Ann Thorac Med 2010;5:65-6.
143. Powell H, Gibson PG. Inhaled corticosteroid doses in asthma: An evidence-based approach. Med J Aust 2003;178:223-5. (Pubitemid 36329216)
144. Vaquerizo MJ, Casan P, Castillo J, Perpina M, Sanchis J, Sobradillo V, et al. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax 2003;58:204-10. (Pubitemid 36307997)
145. Joos S, Miksch A, Szecsenyi J, Wieseler B, Grouven U, Kaiser T, et al. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: A systematic review. Thorax 2008;63:453-62. (Pubitemid 351698876)
146. Zeiger RS, Szefler SJ, Phillips BR, Schatz M, Martinez FD, Chinchilli VM, et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 2006;117:45-52. (Pubitemid 43017138)
147. Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997;337:1412-8.
148. Bateman ED, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol 2011;128:315-22.
149. Smith LJ. Anticholinergics for patients with asthma? N Engl J Med 2010;363:1764-5.
150. Al-Hajjaj MS. Diffcult-to-treat asthma, is it really diffcult? Ann Thorac Med 2011;6:1-2.
151. Pauwels RA, Lofdahl CG, Postma DS, Tattersfeld AE, O'Byrne P, Barnes PJ, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-11.
152. Virchow JC, Jr., Prasse A, Naya I, Summerton L, Harris A. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med 2000;162(2 Pt 1):578-85. (Pubitemid 30647203)
153. American Lung Association Asthma Clinical Research C. Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma. Am J Respir Crit Care Med 2007;175:235-42.
154. Kerstjens HA, Disse B, Schroder-Babo W, Bantje TA, Gahlemann M, Sigmund R, et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: A randomized controlled trial. J Allergy Clin Immunol 2011;128:308-14.
155. Rivington RN, Boulet LP, Cote J, Kreisman H, Small DI, Alexander M, et al. Effcacy of Uniphyl, salbutamol, and their combination in asthmatic patients
156. Waldeck B. Enantiomers of bronchodilating beta2-adrenoceptor agonists: Is there a cause for concern? J Allergy Clin Immunol 1999;103(5 Pt 1):742-8. (Pubitemid 29297572)
157. Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: A practice parameter third update. J Allergy Clin Immunol 2011;127(1 Suppl):S1-55.
158. Madsen F. EAACI 'Standards for practical allergen-specific immunotherapy'. Allergy 2007;62:332.
159. Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Malling HJ, Valovirta E, et al. Standards for practical allergenspecifc immunotherapy. Allergy 2006;61 Suppl 82:1-20.
160. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Host A, et al. Specifc immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007;62:943-8. (Pubitemid 47037870)
161. Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002;109:251-6. (Pubitemid 34158289)
162. Eng PA, Reinhold M, Gnehm HP. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy 2002;57:306-12. (Pubitemid 34280657)
163. Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP. Twelveyear follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy 2006;61:198-201. (Pubitemid 43381830)
164. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Allergen immunotherapy: A practice parameter second update. J Allergy Clin Immunol 2007;120(3 Suppl):S25-85.
165. Jacobsen L. Preventive aspects of immunotherapy: Prevention for children at risk of developing asthma. Ann Allergy Asthma Immunol 2001;87(1 Suppl 1):43-6. (Pubitemid 32661329)
166. Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010:CD001186.
167. Kopp MV. Role of immunmodulators in allergen-specific immunotherapy. Allergy 2011;66:792-7.
168. Sandstrom T. Omalizumab in the management of patients with allergic (IgE-mediated) asthma. J Asthma Allergy 2009;2:49-62.
169. Stock P, Rolinck-Werninghaus C, Wahn U, Hamelmann E. The role of anti-IgE therapy in combination with allergen specifc immunotherapy for seasonal allergic rhinitis: Clinical immunotherapeutics, biopharmaceuticals and gene therapy. BioDrugs 2007;21:403-10. (Pubitemid 350145448)
170. Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A. Differences between asthma exacerbations and poor asthma control. Lancet 1999;353:364-9. (Pubitemid 29088164)
171. Al-Dawood KM. Pattern and risk factors associated with hospital emergency visits among schoolboys with bronchial Asthma in Al-Khobar. Ann Saudi Med 2002;22:29-33. (Pubitemid 34919016)
172. Courtney AU, McCarter DF, Pollart SM. Childhood asthma: Treatment update. Am Fam Physician 2005;71:1959-68. (Pubitemid 40695958)
173. O'Driscoll BR, Howard LS, Davison AG; British Thoracic S. BTS guideline for emergency oxygen use in adult patients. Thorax 2008;63 Suppl 6:vi1-68.
174. McFadden ER Jr. Critical appraisal of the therapy of asthma-an idea whose time has come. Am Rev Respir Dis 1986;133:723-4.
175. Rossing TH, Fanta CH, Goldstein DH, Snapper JR, McFadden ER, Jr. Emergency therapy of asthma: Comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline. Am Rev Respir Dis 1980;122:365-71.
176. Lanes SF, Garrett JE, Wentworth CE, 3rd, Fitzgerald JM, Karpel JP. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: A pooled analysis of three trials. Chest 1998;114:365-72. (Pubitemid 28387509)
177. Stoodley RG, Aaron SD, Dales RE. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: A metaanalysis of randomized clinical trials. Ann Emerg Med 1999;34:8-18. (Pubitemid 29295746)
178. Rodrigo G, Rodrigo C, Burschtin O. A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. Am J Med. 1999;107:363-70. (Pubitemid 29465815)
179. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2001; CD002178.
180. Rowe BH, Bota GW, Fabris L, Therrien SA, Milner RA, Jacono J. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: A randomized controlled trial. JAMA 1999;281:2119-26. (Pubitemid 29264691)
181. Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CA, Jr. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000:CD001490.
182. Parameswaran K, Belda J, Rowe BH. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database Syst Rev 2000; CD002742.
183. Graham VA, Milton AF, Knowles GK, Davies RJ. Routine antibiotics in hospital management of acute asthma. Lancet 1982;1:418-20.
184. Badminton MN, Campbell AK, Rembold CM. Differential regulation of nuclear and cytosolic Ca2+ in HeLa cells. J Biol Chem 1996;271:31210-4. (Pubitemid 26408565)
185. Anagnostou K, Harrison B, Iles R, Nasser S. Risk factors for childhood asthma deaths from the UK Eastern Region Confdential Enquiry 2001-2006. Primary care respiratory journal: Journal of the General Practice Airways Group. 2012;21(1):71-7. Epub 2012/01/06.
186. Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992;326:501-6.
187. Suissa S, Blais L, Ernst P. Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma. Eur Respir J 1994;7:1602-9. (Pubitemid 24294244)
188. Rowe BH, Keller JL, Oxman AD. Effectiveness of steroid therapy in acute exacerbations of asthma: A meta-analysis. Am J Emerg Med 1992;10:301-10.
189. Chien JW, Ciufo R, Novak R, Skowronski M, Nelson J, Coreno A, et al. Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest 2000;117:728-33. (Pubitemid 30152212)
190. Kerem E, Levison H, Schuh S, O'Brodovich H, Reisman J, Bentur L, et al. Effcacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr 1993;123:313-7. (Pubitemid 23221119)
191. Rodrigo C, Rodrigo G. Salbutamol treatment of acute severe asthma in the ED: MDI versus hand-held nebulizer. Am J Emerg Med 1998;16:637-42. (Pubitemid 28523534)
192. Cates CC, Bara A, Crilly JA, Rowe BH. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2003:CD000052.
193. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2001:CD002178.
194. Tokuda Y, Miyagi S. Oxygen treatment for acute severe asthma. Home oxygenation would be more effective. BMJ 2001;323:1069. (Pubitemid 33042316)
195. Inwald D, Roland M, Kuitert L, McKenzie SA, Petros A. Oxygen treatment for acute severe asthma. BMJ 2001;323:98-100. (Pubitemid 32681978)
196. Gleeson JG, Green S, Price JF. Air or oxygen as driving gas for nebulised salbutamol. Arch Dis Child 1988;63:900-4.
197. Douglas JG, Rafferty P, Fergusson RJ, Prescott RJ, Crompton GK, Grant IW. Nebulised salbutamol without oxygen in severe acute asthma: How effective and how safe? Thorax 1985;40:180-3. (Pubitemid 15108301)
198. Chassany O, Fullerton S. Meta-analysis of the effects of ipratropium bromide in adults with acute asthma. Am J Med 2000;108:596-7. (Pubitemid 30249044)
199. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev 2007; CD000195.
200. Shrestha M, Bidadi K, Gourlay S, Hayes J. Continuous vs intermittent albuterol, at high and low doses, in the treatment of severe acute asthma in adults. Chest 1996;110:42-7. (Pubitemid 26249299)
201. Lin RY, Sauter D, Newman T, Sirleaf J, Walters J, Tavakol M. Continuous versus intermittent albuterol nebulization in the treatment of acute asthma. Ann Emerg Med 1993;22:1847-53. (Pubitemid 23346159)
202. Fitzgerald JM, Baynham R, Powles AC. Use of oxygen therapy for adult patients outside the critical care areas of a university hospital. Lancet 1988;1:981-3.
203. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev 2007; CD000195.
204. Masoli M, Fabian D, Holt S, Beasley R, Global Initiative for Asthma P. The global burden of asthma: Executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469-78. (Pubitemid 38580764)
205. Edmonds ML, Camargo CA, Jr., Pollack CV, Jr., Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev 2003; CD002308.
206. van den Akker-van Marle ME, Bruil J, Detmar SB. Evaluation of cost of disease: Assessing the burden to society of asthma in children in the European Union. Allergy 2005;60:140-9. (Pubitemid 40187466)
207. Denlinger LC, Sorkness CA, Chinchilli VM, Lemanske RF, Jr. Guideline-defning asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network. J Allergy Clin Immunol 2007;119:3-11; quiz 12-3. (Pubitemid 46043384)
208. Pedersen SE, Hurd SS, Lemanske RF, Jr., Becker A, Zar HJ, Sly PD, et al. Global strategy for the diagnosis and management of asthma in children 5 years and younger. Pediatr Pulmonol 2011;46:1-17.
209. Glauber JH, Fuhlbrigge AL, Finkelstein JA, Homer CJ, Weiss ST. Relationship between asthma medication and antibiotic use. Chest 2001;120:1485-92. (Pubitemid 33078462)
210. Seear M, Wensley D, West N. How accurate is the diagnosis of exercise induced asthma among Vancouver schoolchildren? Arch Dis Child 2005;90:898-902. (Pubitemid 41232337)
211. Fahy JV, O'Byrne PM. "Reactive airways disease". A lazy term of uncertain meaning that should be abandoned. Am J Respir Crit Care Med 2001;163:822-3. (Pubitemid 32275849)
212. Weinberger M. Pediatric asthma and related allergic and nonallergic diseases: Patient-oriented evidence-based essentials that matter. Pediatric Health 2008;2:631-50.
213. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the frst six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133-8.
214. Just J, Gouvis-Echraghi R, Couderc R, Guillemot-Lambert N, Saint-Pierre P. Novel severe wheezy young children phenotypes: Boys atopic multiple-trigger and girls nonatopic uncontrolled wheeze. J Allergy Clin Immunol 2012;130:103-10. e8.
215. Guilbert TW, Morgan WJ, Zeiger RS, Bacharier LB, Boehmer SJ, Krawiec M, et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol 2004;114:1282-7. (Pubitemid 39575879)
216. Castro-Rodriguez JA. The Asthma Predictive Index: A very useful tool for predicting asthma in young children. J Allergy Clin Immunol 2010;126:212-6.
217. Yawn BP, Brenneman SK, Allen-Ramey FC, Cabana MD, Markson LE. Assessment of asthma severity and asthma control in children. Pediatrics 2006;118:322-9. (Pubitemid 46071178)
218. Welsh EJ, Hasan M, Li P. Home-based educational interventions for children with asthma. Cochrane Database Syst Rev 2011; CD008469.
219. Wolf FM, Guevara JP, Grum CM, Clark NM, Cates CJ. Educational interventions for asthma in children. Cochrane Database Syst Rev. 2003; (1): CD000326.
220. Wood MR, Bolyard D. Making education count: The nurse's role in asthma education using a medical home model of care. J Pediatr Nurs 2011;26:552-8.
221. Becker A, Lemiere C, Berube D, Boulet LP, Ducharme FM, Fitz Gerald M, et al. Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003 CMAJ 2005;173(6 Suppl):S3-11. (Pubitemid 41345553)
222. Cope SF, Ungar WJ, Glazier RH. International differences in asthma guidelines for children. Int Arch Allergy Immunol 2009;148:265-78.
223. Zeiger RS, Mellon M, Chipps B, Murphy KR, Schatz M, Kosinski M, et al. Test for Respiratory and Asthma Control in Kids (TRACK): Clinically meaningful changes in score. J Allergy Clin Immunol 2011;128:983-8.
224. Liu AH, Zeiger RS, Sorkness CA, Ostrom NK, Chipps BE, Rosa K, et al. The Childhood Asthma Control Test: Retrospective determination and clinical validation of a cut point to identify children with very poorly controlled asthma. J Allergy Clin Immunol 2010;126:267-73, 73 e1.
225. Murphy KR, Zeiger RS, Kosinski M, Chipps B, Mellon M, Schatz M, et al. Test for respiratory and asthma control in kids (TRACK): A caregiver-completed questionnaire for preschoolaged children. J Allergy Clin Immunol 2009;123:833-9. e9.
226. Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 2007;119:817-25. (Pubitemid 46527825)
227. Bisgaard H, Allen D, Milanowski J, Kalev I, Willits L, Davies P. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics 2004;113:e87-94.
228. Lefein JG, Szefer SJ, Murphy KR, Fitzpatrick S, Cruz-Rivera M, Miller CJ, et al. Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: Results of a randomized outcomes trial. Pediatrics 2002;109:866-72. (Pubitemid 34493354)
229. Dufour V, Millon L, Faucher JF, Bard E, Robinet E, Piarroux R, et al. Effects of a short-course of amoxicillin/clavulanic acid on systemic and mucosal immunity in healthy adult humans. Int Immunopharmacol 2005;5:917-28. (Pubitemid 40381125)
230. Hedlin G, Svedmyr J, Ryden AC. Systemic effects of a short course of betamethasone compared with high-dose inhaled budesonide in early childhood asthma. Acta Paediatr 1999;88:48-51. (Pubitemid 29100199)
231. Ducharme FM, Hicks GC. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev 2002:CD002314.
232. Phipatanakul W, Cronin B, Wood RA, Eggleston PA, Shih MC, Song L, et al. Effect of environmental intervention on mouse allergen levels in homes of inner-city Boston children with asthma. Ann Allergy Asthma Immunol 2004;92:420-5. (Pubitemid 39077583)
233. Ducharme FM. Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: Systematic review of current evidence. BMJ 2002;324:1545.
234. Simons FE, Villa JR, Lee BW, Teper AM, Lyttle B, Aristizabal G, et al. Montelukast added to budesonide in children with persistent asthma: A randomized, double-blind, crossover study. J Pediatr 2001;138:694-8. (Pubitemid 32417670)
235. Hakim F, Vilozni D, Adler A, Livnat G, Tal A, Bentur L. The effect of montelukast on bronchial hyperreactivity in preschool children. Chest 2007;131:180-6. (Pubitemid 46122990)
236. de Benedictis FM, del Giudice MM, Forenza N, Decimo F, de Benedictis D, Capristo A. Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children. Eur Respir J 2006;28:291-5. (Pubitemid 44914226)
237. Lazarus SC, Boushey HA, Fahy JV, Chinchilli VM, Lemanske RF, Jr., Sorkness CA, et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: A randomized controlled trial. JAMA 2001;285:2583-93. (Pubitemid 32479898)
238. Shrewsbury S, Pyke S, Britton M. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). BMJ 2000;320:1368-73. (Pubitemid 30261116)
239. Matz J, Emmett A, Rickard K, Kalberg C. Addition of salmeterol to low-dose futicasone versus higher-dose futicasone: An analysis of asthma exacerbations. J Allergy Clin Immunol 2001;107:783-9. (Pubitemid 32436910)
240. Everard ML, Bara A, Kurian M, Elliott TM, Ducharme F, Mayowe V. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database Syst Rev 2005:CD001279.
241. Castro-Rodriguez JA, Rodrigo GJ. beta-agonists through metereddose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: A systematic review with meta-analysis. J Pediatr 2004;145:172-7. (Pubitemid 38993387)
242. Deerojanawong J, Manuyakorn W, Prapphal N, Harnruthakorn C, Sritippayawan S, Samransamruajkit R. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhalerspacer vs. jet nebulizer in young children with wheezing. Pediatr Pulmonol 2005;39:466-72. (Pubitemid 40548291)
243. Agertoft L, Pedersen S. Importance of training for correct Turbuhaler use in preschool children. Acta Paediatr 1998;87:842-7. (Pubitemid 28409060)
244. Drblik S, Lapierre G, Thivierge R, Turgeon J, Gaudreault P, Cummins-McManus B, et al. Comparative effcacy of terbutaline sulphate delivered by Turbuhaler dry powder inhaler or pressurised metered dose inhaler with Nebuhaler spacer in children during an acute asthmatic episode. Arch Dis Child 2003;88:319-23. (Pubitemid 36398970)
245. Ducharme FM, Chalut D, Plotnick L, Savdie C, Kudirka D, Zhang X, et al. The Pediatric Respiratory Assessment Measure: A valid clinical score for assessing acute asthma severity from toddlers to teenagers. J Pediatr 2008;152:476-80, 480.e1.
246. Birken CS, Parkin PC, Macarthur C. Asthma severity scores for preschoolers displayed weaknesses in reliability, validity, and responsiveness. J Clin Epidemiol 2004;57:1177-81. (Pubitemid 39573025)
247. Parkin PC, Macarthur C, Saunders NR, Diamond SA, Winders PM. Development of a clinical asthma score for use in hospitalized children between 1 and 5 years of age. J Clin Epidemiol 1996;49:821-5. (Pubitemid 26283391)
248. Bentur L, Kerem E, Canny G, Reisman J, Schuh S, Stein R, et al. Response of acute asthma to a beta 2 agonist in children less than two years of age. Ann Allergy 1990;65:122-6. (Pubitemid 20259591)
249. Wennergren G, Engstrom I, Bjure J. Transcutaneous oxygen and carbon dioxide levels and a clinical symptom scale for monitoring the acute asthmatic state in infants and young children. Acta Paediatr Scand 1986;75:465-9. (Pubitemid 16064153)
250. Tal A, Bavilski C, Yohai D, Bearman JE, Gorodischer R, Moses SW. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics 1983;71:13-8. (Pubitemid 13190054)
251. Bentur L, Canny GJ, Shields MD, Kerem E, Schuh S, Reisman JJ, et al. Controlled trial of nebulized albuterol in children younger than 2 years of age with acute asthma. Pediatrics 1992;89:133-7.
252. Tal A, Levy N, Bearman JE. Methylprednisolone therapy for acute asthma in infants and toddlers: A controlled clinical trial. Pediatrics 1990;86:350-6. (Pubitemid 20334965)
253. Chalut DS, Ducharme FM, Davis GM. The Preschool Respiratory Assessment Measure (PRAM): A responsive index of acute asthma severity. J Pediatr 2000;137:762-8.
254. Norton SP, Pusic MV, Taha F, Heathcote S, Carleton BC. Effect of a clinical pathway on the hospitalisation rates of children with asthma: A prospective study. Arch Dis Child 2007;92:60-6. (Pubitemid 46132936)
255. Lougheed MD, Olajos-Clow JG. Asthma care pathways in the emergency department. Curr Opin Allergy Clin Immunol 2010;10:181-7.
256. Browne GJ, Giles H, McCaskill ME, Fasher BJ, Lam LT. The benefts of using clinical pathways for managing acute paediatric illness in an emergency department. J Qual Clin Pract 2001;21:50-5. (Pubitemid 33120983)
257. Alberta Health Services, Pediatric Asthma Pathways. Available from: http://www.ucalgary.ca/icancontrolasthma/pathwayall. [Last accessed on 2012 Sep. 16].
258. Johnson KB, Blaisdell CJ, Walker A, Eggleston P. Effectiveness of a clinical pathway for inpatient asthma management. Pediatrics 2000;106:1006-12.
259. Dicpinigaitis PV. Angiotensin-converting enzyme inhibitorinduced cough: ACCP evidence-based clinical practice guidelines. Chest 2006;129(1 Suppl):169S-73S. (Pubitemid 43265218)
260. Dicpinigaitis PV. Chronic cough due to asthma: ACCP evidencebased clinical practice guidelines. Chest 2006;129(1 Suppl):75S-9S. (Pubitemid 43265208)
261. Morice AH, McGarvey L, Pavord I, British Thoracic Society Cough Guideline G. Recommendations for the management of cough in adults. Thorax 2006;61 Suppl 1:i1-24. (Pubitemid 44369412)
262. Sears MR, Lotvall J. Past, present and future-beta2-adrenoceptor agonists in asthma management. J Pediatr 2000;137:762-8.
263. Szczeklik A, Stevenson DD. Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003;111:913-21; quiz 922. (Pubitemid 36570845)
264. Stevenson DD. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-infammatory drugs. J Allergy Clin Immunol 1984;74(4 Pt 2):617-22. (Pubitemid 15200696)
265. Al-Asoom LI, Al-Rubaish A, Al-Quorain AA, Qutub H, El-Munshid HA. The association of gastroesophageal reflux with bronchial asthma. Can asthma also trigger reflux? Hepatogastroenterology 2006;53:64-72. (Pubitemid 43287396)
266. Bresci G, Sacco R. Pulmonary or otolaryngologic extraesophageal manifestations in patients with gastroesophageal refux disease. World J Gastrointest Endosc 2010;2:47-9.
267. Gaude GS. Pulmonary manifestations of gastroesophageal refux disease. Ann Thorac Med 2009;4:115-23.
268. Champion GL, Richter JE. Atypical presentation of gastroesophageal refux disease: Chest pain, pulmonary, and ear, nose, throat manifestations. Gastroenterologist 1993;1:18-33.
269. Asano K, Suzuki H. Silent acid refux and asthma control. N Engl J Med 2009;360:1551-3.
270. Namazy JA, Schatz M. Pregnancy and asthma: Recent developments. Curr Opin Pulm Med 2005;11:56-60. (Pubitemid 40189252)
271. Schatz M, Harden K, Forsythe A, Chilingar L, Hoffman C, Sperling W, et al. The course of asthma during pregnancy, post partum, and with successive pregnancies: A prospective analysis. J Allergy Clin Immunol 1988;81:509-17. (Pubitemid 18089929)
272. Murphy VE, Gibson PG, Smith R, Clifton VL. Asthma during pregnancy: Mechanisms and treatment implications. Eur Respir J 2005;25:731-50. (Pubitemid 40528770)
273. Hanania NA, Belfort MA. Acute asthma in pregnancy. Crit Care Med 2005;33(10 Suppl):S319-24. (Pubitemid 41437457)
274. Rahimi R, Nikfar S, Abdollahi M. Meta-analysis fnds use of inhaled corticosteroids during pregnancy safe: A systematic meta-analysis review. Hum Exp Toxicol 2006;25:447-52. (Pubitemid 44384586)
275. Wendel PJ, Ramin SM, Barnett-Hamm C, Rowe TF, Cunningham FG. Asthma treatment in pregnancy: A randomized controlled study. Am J Obstet Gynecol 1996;175:150-4. (Pubitemid 26282221)
276. Lao TT, Huengsburg M. Labour and delivery in mothers with asthma. Eur J Obstet Gynecol Reprod Biol 1990;35:183-90. (Pubitemid 20184060)
277. Fitzsimons R, Greenberger PA, Patterson R. Outcome of pregnancy in women requiring corticosteroids for severe asthma. J Allergy Clin Immunol 1986;78:349-53. (Pubitemid 16039642)
278. Perlow JH, Montgomery D, Morgan MA, Towers CV, Porto M. Severity of asthma and perinatal outcome. Am J Obstet Gynecol 1992;167(4 Pt 1):963-7.
279. Currie GP, Douglas JG, Heaney LG. Diffcult to treat asthma in adults. BMJ 2009;338:b494.
280. Sullivan SD, Rasouliyan L, Russo PA, Kamath T, Chipps BE, Group TS. Extent, patterns, and burden of uncontrolled disease in severe or diffcult-to-treat asthma. Allergy 2007;62:126-33. (Pubitemid 46090293)
281. Serra-Batlles J, Plaza V, Morejon E, Comella A, Brugues J. Costs of asthma according to the degree of severity. Eur Respir J 1998;12:1322-6. (Pubitemid 29011423)
282. Chen H, Blanc PD, Hayden ML, Bleecker ER, Chawla A, Lee JH, et al. Assessing productivity loss and activity impairment in severe or diffcult-to-treat asthma. Value Health 2008;11:231-9. (Pubitemid 351473606)
283. Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent airflow limitation in severe or diffcult-to-treat asthma: Insights from the TENOR study. Chest 2007;132:1882-9.
284. Sturdy PM, Victor CR, Anderson HR, Bland JM, Butland BK, Harrison BD, et al. Psychological, social and health behaviour risk factors for deaths certifed as asthma: A national case-control study. Thorax 2002;57:1034-9. (Pubitemid 35440762)
285. Butler C, Heaney LG. Risk factors of frequent exacerbations in diffcult-to-treat asthma. Eur Respir J. 2006;27:1324-5. (Pubitemid 44914322)
286. Gaga M, Papageorgiou N, Yiourgioti G, Karydi P, Liapikou A, Bitsakou H, et al. Risk factors and characteristics associated with severe and diffcult to treat asthma phenotype: An analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire. Clin Exp Allergy 2005;35:954-9. (Pubitemid 41032546)
287. Sullivan SD, Wenzel SE, Bresnahan BW, Zheng B, Lee JH, Pritchard M, et al. Association of control and risk of severe asthmarelated events in severe or diffcult-to-treat asthma patients. Allergy 2007;62:655-60. (Pubitemid 46763446)
288. Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF, et al. Systematic assessment of diffcult-to-treat asthma. Eur Respir J 2003;22:478-83.
289. Jani AL, Hamilos DL. Current thinking on the relationship between rhinosinusitis and asthma. J Asthma 2005;42:1-7. (Pubitemid 40365722)
290. Heaney LG, Brightling CE, Menzies-Gow A, Stevenson M, Niven RM; British Thoracic Society Diffcult Asthma Network. Refractory asthma in the UK: Cross-sectional fndings from a UK multicentre registry. Thorax 2010;65:787-94.
291. Adcock IM, Lane SJ, Brown CR, Peters MJ, Lee TH, Barnes PJ. Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J Immunol. 1995;154:3500-5.
292. Ayres JG. Pseudo-steroid resistant asthma. Thorax 1999;54:956.
293. Thomas PS, Geddes DM, Barnes PJ. Pseudo-steroid resistant asthma. Thorax 1999;54:352-6. (Pubitemid 29150165)
294. Roberts NJ, Robinson DS, Partridge MR. How is diffcult asthma managed. Eur Respir J 2006;28:968-73.
295. Smits W, Letz K. Managing diffcult-to-treat asthma: Lessons from a center of excellence in allergy and asthma care. J Med Pract Manage 2007;22:350-8.
296. Storms W, Bowdish MS, Farrar JR. Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: A 6-year pragmatic data review. Allergy Asthma Proc 2012;33:172-7.
297. Campbell JD, Blough DK, Sullivan SD. Comparison of guidelinebased control defnitions and associations with outcomes in severe or diffcult-to-treat asthma. Ann Allergy Asthma Immunol 2008;101:474-81.
298. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973-84.
299. Pavord ID, Cox G, Thomson NC, Rubin AS, Corris PA, Niven RM, et al. Safety and effcacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med. 2007;176:1185-91. (Pubitemid 350256471)
300. Michaud G, Ernst A. Counterpoint: Efficacy of bronchial thermoplasty for patients with severe asthma. Is there suffcient evidence? Not yet. Chest 2011;140:576-7; discussion 577.
301. Shifren A, Chen A, Castro M. Point: Efficacy of bronchial thermoplasty for patients with severe asthma. Is there suffcient evidence? Yes. Chest 2011;140:573-5; discussion 578.
302. Wu Q, Xing Y, Zhou X, Wang D. Meta-analysis of the effcacy and safety of bronchial thermoplasty in patients with moderateto-severe persistent asthma. J Int Med Res 2011;39:10-22.
303. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-36.